Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
23 Jan 2025
BRCA1/BRCA2
Carriers Face Elevated Risk of Second Cancers
BRCA1/BRCA2 carriers face significantly higher risks of second cancers, including ovarian and pancreatic, after breast cancer.
23 Jan 2025
15% of Children Aged Under 3 Years Receive Invalid Vaccine Doses
Research reveals that 15% of children aged 0–35 months in the USA received at least one invalid vaccine dose between 2011–2020.
23 Jan 2025
Wearable Tech Predicts IBD Flares Weeks in Advance
Wearable devices like Apple Watches, Fitbits, and Oura Rings could revolutionise inflammatory bowel disease (IBD) management.
7
Mins
23 Jan 2025
Exploring Hepatocellular Carcinoma: Massimo Colombo
EMJ is thrilled to present an interview with Massimo Colombo, Past Professor of Gastroenterology at the University of Milan, Italy, that…
23 Jan 2025
Study Explores Acne Relapse Rates After Isotretinoin
The study revealed that 22.5% of patients experienced acne relapse, and 8.2% required isotretinoin retrial.
Takeda takes lead role in Crohn’s Disease biomarker study
Takeda is serving as the Industry Lead in the newly launched INTERCEPT project – a multinational collaboration to identify predictive biomarkers for Crohn’s Disease.
22 Jan 2025
Deep Learning Tool Identifies Heart Failure with Reduced Ejection Fraction
AI model automates heart failure identification, offering precision and paving the way for improved quality assessments.
22 Jan 2025
Holistic Approaches to Relieve Lower Urinary Tract Symptoms
In a recent double-blind clinical trial, S. miltiorrhiza extract improved LUTS-related quality of life scores comparably to existing drugs, with notable safety advantages.
5 minutes with... Dr Matthew Hickling, Allergan Aesthetics
Dr Matthew Hickling explores the science behind beauty, his role in aesthetics and the opportunities shaping the future of the field.
22 Jan 2025
New Decision Tool Improves COPD Outcomes While Reducing Antibiotics
The Prospector calculator reduces antibiotic use by nearly half in COPD exacerbations, showing promise for safer and more effective patient care.
←
1
2
3
…
35
36
37
38
39
40
41
…
1,042
1,043
1,044
→